Background: Cyclic vomiting syndrome (CVS) is a functional gastrointestinal disorder
IV criteria for the diagnosis of CVS in adults consists of at least three episodes of acute vomiting in the previous 12 months, lasting less than 1 week, with two episodes in the last 6 months occurring at least 1 week apart, and the absence of vomiting between episodes, although there is a recognition that milder symptoms, such as nausea, may be present in between these episodes. 7 Despite the development of diagnostic criteria for CVS in adults, the condition remains under-recognized, even though vomiting itself is a common complaint, with up to 3% of individuals reporting it in cross-sectional surveys in the community. 8 The average age of onset of symptoms of CVS in the adult population is 22 years, yet the average age of individuals at the time the diagnosis is made is 31 years.
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This substantial delay in diagnosis may be due to a lack of awareness of CVS as a clinical entity, or a failure to ask pertinent questions when eliciting a clinical history.
Although there are numerous case series of adult patients with CVS, 10-15 the majority of these contain few patients, and therefore the epidemiology of CVS in adults remains poorly understood, with few true prevalence data. There is also a lack of studies reporting demographic or clinical features associated with the condition. The aims of this study were therefore to estimate the prevalence of CVS in a large number of consecutive unselected referrals with GI symptoms in secondary care, and to assess the degree to which the possibility of a diagnosis of CVS was considered, and to examine associated features in those meeting criteria for CVS, in order to better understand the epidemiology of the condition in adults.
| MATERIALS AND METHODS

| Participants and setting
Unselected, consecutive patients aged ≥16 years were recruited. All were newly referred from primary care to secondary care for consideration of investigation of upper and/or lower GI symptoms. These individuals were approached in six medical gastroenterology outpatient clinics in the Leeds Teaching Hospitals Trust, West Yorkshire, United
Kingdom. These hospitals provide secondary care services to a local population of almost 800 000 people in Northern England. All study questionnaires were self-administered, meaning that inability to read written English precluded inclusion in the study. There were no other exclusion criteria.
Before seeing a gastroenterologist at their initial clinic visit, all subjects were given a study information sheet. Following agreement to participate, written informed consent was gained from each person. Symptom data were collected prospectively at the initial clinic visit.
The Rome III diagnostic questionnaire for adult functional GI disorders was used to collect data on GI symptoms. 19 In addition to this, we recorded if vomiting symptoms were documented as present or absent by the physician in the clinical notes at the initial consultation, and if a diagnosis of CVS was considered by the responsible gastroenterologist in those patients who met the Rome III criteria for the condition.
Data concerning psychiatric comorbidity were also collected in these patients. We used the validated hospital anxiety and depression scale (HADS) to assess mood. 20 This contains 14 questions; seven relating to anxiety and seven to depression. Each question is scored from 0 to 3, equating to a maximum score of 21. A score of ≥8 was used to identify possible anxiety or depression. Somatization-type behavior was assessed using the validated patient health questionnaire-15 (PHQ-15).
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This uses 15 questions, each scoring from 0 to 2, assessing individual somatic symptoms giving a potential maximum score of 30. A score of ≥15 is the validated value to identify high levels of somatization.
All questionnaire data were entered into a database by trained researchers who were not involved in the clinical care of the patient, thus ensuring that assessors were blinded to symptom status.
Key Points
• Epidemiology of cyclic vomiting syndrome (CVS) in adults is poorly understood. Lack of awareness of CVS as an entity may delay diagnosis. We examined these issues in adults in secondary care.
• Approximately 11% of patients in secondary care met criteria for CVS. Symptoms of vomiting were poorly elicited.
The diagnosis was considered in a minority. Psychiatric comorbidity was common.
• Education of physicians likely to encounter patients with CVS may eliminate diagnostic delay, reduce financial burden, and enable appropriate management.
| Definition of CVS
Symptoms compatible with a diagnosis of CVS were identified using the scoring system proposed by the validated Rome III questionnaire (Table 1) . 19 The final diagnosis in each patient was obtained by accessing their clinical records, only after completion of all relevant investigations. A study diagnosis of CVS was applied to those individuals meeting the Rome III criteria after appropriate investigations had failed to reveal an organic cause of their symptoms, to the level of investigation deemed appropriate by the responsible gastroenterologist.
| Statistical analysis
We compared demographic data of those with CVS with those of all other patients consulting with GI symptoms using a χ 2 test for categorical data, and an independent samples t test for continuous data, with a mean and standard deviation (SD). Because of multiple comparisons a 2-tailed P value of <.01 was considered statistically significant for these analyses. All statistical analyses were performed using SPSS for Windows version 21.0 (SPSS Inc., Chicago, IL, USA).
| RESULTS
Between January 2014 and December 2015 a total of 1002 patients with upper and/or lower GI symptoms consented to take part in the study; 638 were female (63.7%) and the mean age of included individu- patients met the Rome III criteria for CVS ( Figure 1 ). However, 13
(11.6%) of these patients had an organic diagnosis that would potentially explain their symptoms, after investigation to the level deemed appropriate by the responsible physician. These included confirmed gastroparesis in three, large hiatus hernia in three, confirmed esophageal dysmotility in two, achalasia in one, intermittent small bowel obstruction in one, duodenal stricture in one, esophageal adenocarcinoma in one, and peritoneal metastases in one.
| Prevalence of CVS
The remaining 99 (88.4%) patients meeting Rome III criteria for CVS had no organic cause found to explain their GI symptoms, following investigation to a level deemed appropriate by the responsible gastroenterologist.
These 99 patients were therefore defined as having CVS, giving a prevalence in this secondary care population of 920 patients of 10.8% (95% confidence interval 8.9% to 12.9%). Only 39 (39.4%) of these 99 patients had any documentation in their clinical notes as to whether vomiting was present or absent at their initial consultation. In addition, a diagnosis of CVS was considered in only four (4.0%) of these 99 patients with CVS.
| Features of patients with CVS
Of the 99 patients deemed to have CVS, 73 (73.7%) were female, and the mean age was 47.3 years. Comparison of those with CVS with all other patients with GI symptoms consulting in secondary care
revealed that those with CVS were significantly younger ( Table 2 ).
In addition, there was a statistically significant association between the presence of CVS and tobacco smoking, and a trend toward an 
| DISCUSSION
This study confirms that CVS is prevalent in an outpatient gastroenterology population, with almost 11% of patients seen in a secondary care clinic meeting the Rome III criteria. However, the condition remains under-recognized, with the diagnosis considered in only four (4.0%) of the 99 patients who met these criteria. The commonest organic explanations for symptoms in patients who were initially T A B L E 2 Demographics and baseline characteristics of patients with CVS compared with patients with other GI symptoms not meeting criteria for CVS thought to have CVS prior to investigation included esophageal or gastric dysmotility and large hiatus hernia. In addition, one patient was found to have esophageal adenocarcinoma, a second had a duodenal stricture, and a third had peritoneal metastases. Younger age and tobacco smoking were both associated with the presence of CVS, and anxiety, depression, and somatization scores were all higher than in other patients with GI symptoms.
We recruited a large number of unselected patients with GI symptoms in secondary care, and none of the physicians consulting in the six outpatient gastroenterology clinics we recruited from has a specialist interest in this area, meaning that our results are likely to be generalizable to other patients seen in outpatient gastroenterology clinics.
We collected data concerning a wide range of demographic variables, other GI symptoms, and psychological health, using validated questionnaires, and all patients included were investigated to the level deemed to be appropriate by the responsible gastroenterologist, prior to a diagnosis of CVS being applied.
Weaknesses of the study include the fact that, although we recruited a large sample of patients, the actual number with CVS was small, reflecting that this is a relatively uncommon condition, meaning that we may have lacked sufficient power to detect some genuine associations between CVS and demographics, lifestyle, symptoms compatible with other functional GI disorders, and psychiatric comorbidity.
In addition, >90% of the patients involved were White, meaning that the results of this study cannot be generalized to other ethnicities, and the population with CVS was older than in other studies, 11, 12, 15 which may reflect volunteer bias. We did not mandate a standard level of investigation to exclude an organic cause for symptoms suggestive of CVS, due to the fact that the study was conducted in routine clinical practice. This meant that there was no consistent diagnostic algorithm applied to patients to rule out possible organic causes of symptoms prior to a label of CVS being applied. As studying the prevalence of, and associations with, CVS was not the original primary objective of this cross-sectional survey; we did not collect data routinely on other lifestyle choices known to be associated with CVS, such as cannabis use. 22 Finally, ethical approval was granted on the basis that we were not to collect any data from individuals who did not participate, and patients were allowed to refuse to participate without giving a reason. This is generally the case in cross-sectional surveys, such as this. We cannot therefore assess how representative the 1002 patients we recruited into the present study were of the 2200 new outpatient referrals seen during the study period, nor can we provide data as to why 1198 people declined to take part.
Studies from the pediatric literature suggest the prevalence of symptoms meeting criteria for CVS in children and adolescents in the general population are between 0.3% and 1.9%, 4, [23] [24] [25] [26] [27] as high as 6.1%
in primary care populations, 28 and 8% to 10% in a pediatric gastroenterology clinic. 29 The prevalence in the latter two studies among children is similar to that observed in our study in adults. A study from Ireland estimated the incidence of the condition to be 3.15 per 100 000 children per year. 3 However, CVS is an under-studied disorder in the adult population, and a literature search we conducted revealed no available data on the prevalence of the condition in adults in either the community, or among referral populations, although there is a recent large study using a nationwide database that compared demographic and clinical features in hospitalized patients with CVS, compared with hospitalized patients without. 15 Similar to our study, CVS was associated with psychiatric comorbidity, cigarette smoking, and other FGIDs, and the authors estimated that the condition cost the health service $400 million over the 2-year period of the study.
In addition to estimating the prevalence of CVS in adult patients in secondary care, our study highlights a failure of gastroenterologists to consider a diagnosis of CVS in the outpatient clinic. Part of this lack of recognition may relate to a failure to ask pertinent questions in the clinical history, as evidenced by the fact that the presence or absence of vomiting as a symptom was recorded in only one-in-three clinical consultations with the patients in this study. Another possible explanation is the observation that symptoms compatible with CVS in our study overlapped with multiple other functional GI disorders, so it may be that the responsible gastroenterologists were concentrating on other symptoms that they deemed as being more important, or of higher priority, during consultations with these patients. Whatever the reasons, the main findings of our study suggest a need for better recognition of CVS as a potential diagnosis in adult patients with vomiting. The various associations with symptoms of CVS we identified in this study may aid this, and reduce the current diagnostic delay often seen in these patients.
The fact that CVS was associated with psychiatric comorbidity is perhaps not unexpected, given that the association of other FGIDs with mood disorder and somatoform-type behavior is well-described. [30] [31] [32] [33] However, coexistent psychiatric symptoms are not always recognized in patients consulting with physical symptoms. 34 Explanations for this may include the fact that reporting of psychiatric symptoms as the presenting complaint among such patients is rare, 35 clinicians do not always make specific enquiries about them, 36 and there also may be reluctance on the part of physicians to raise the issue of anxiety, depression, or somatoform-type behavior. 37 Our study results highlight that psychiatric comorbidity is an important associated feature of CVS, and should be screened for in any patient meeting criteria for the disorder. This association may also explain the treatment response to antidepressants, such as mirtazapine and tricyclic antidepressants, seen in some patients with chronic nausea and vomiting. [38] [39] [40] There are other aspects of CVS that we have been unable to examine as part of this study. We did not address underlying pathophysiological mechanisms, another poorly studied area in CVS, although there have been a number of potential theories hypothesized previously. These include activation of the corticotrophin-releasing factor signaling system, 41, 42 abnormal gastric motility, 12,43 mitochondrial DNA mutations, 44, 45 and other genetic factors including variants in the RYR2 gene, which is involved in stress-induced calcium channels in autonomic neurons, 46 and polymorphisms in genes encoding endogenous cannabinoid and opioid receptors. 47 In addition, we did not evaluate the subsequent management of these patients, an issue that has been highlighted in the literature as problematic for gastroenterologists, 13 although we have reported data from our center regarding the treatment of CVS previously. 48 In conclusion, the prevalence of CVS among adult patients in secondary care gastroenterology clinics in this study was 10.8%, but the diagnosis was considered in fewer than one-in-twenty individuals with typical symptoms, who had no structural explanation for these, and who likely had CVS. Education of gastroenterologists, and other physicians who are likely to encounter such patients, including those in primary care and the emergency department, is paramount in order to eliminate the diagnostic delay seen in adults, reduce the financial impact of the condition on both primary and secondary healthcare services, and to institute prompt and appropriate treatment in order to improve quality of life for these patients.
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